| |
| |
|
| Insider
Information: |
Bahrt Kenneth |
| Relationship: |
Chief Medical Officer |
| City: |
East Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
147,120 |
|
|
Indirect Shares
|
53,000 |
|
|
| Direct
Value |
$355,285 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
200,120 |
|
|
| Total
Value |
$355,285 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Savient Pharmaceuticals Inc |
SVNTQ |
SVP, Chief Medical Off... |
2013-10-16 |
100,000 |
2011-09-14 |
53,000 |
Premium* |
|
|
Outlook Therapeutics Inc |
OTLK |
Chief Medical Officer |
2018-06-25 |
47,120 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OTLK |
Outlook Therapeutics Inc |
Chief Medical Officer |
• – – |
2018-06-25 |
4 |
S |
$0.85 |
$6,507 |
D/D |
(7,700) |
47,120 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-12-22 |
4 |
S |
$1.13 |
$29,566 |
D/D |
(26,165) |
54,820 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Medical Officer |
• – – |
2016-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
80,985 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Medical Officer |
• – – |
2016-05-13 |
4 |
B |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
2.66 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Chief Medical OfficerOfficer |
• – – |
2016-05-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,985 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2013-10-16 |
4 |
S |
$0.07 |
$589 |
D/D |
(8,000) |
100,000 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2013-10-15 |
4 |
S |
$0.08 |
$5,712 |
D/D |
(70,211) |
108,000 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2013-04-30 |
4 |
AS |
$0.74 |
$925 |
D/D |
(1,250) |
178,211 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2013-02-04 |
4 |
AS |
$1.01 |
$29,941 |
D/D |
(29,000) |
171,750 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2013-01-31 |
4 |
AS |
$1.03 |
$1,339 |
D/D |
(1,300) |
200,750 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2012-10-31 |
4 |
AS |
$1.45 |
$1,450 |
D/D |
(1,000) |
202,050 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2012-08-01 |
4 |
AS |
$0.62 |
$3,069 |
D/D |
(4,950) |
203,050 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2012-02-01 |
4 |
A |
$2.26 |
$339,000 |
D/D |
150,000 |
208,000 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2011-09-14 |
4 |
B |
$3.97 |
$1,983 |
I/I |
500 |
53,000 |
1.91 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2011-09-14 |
4 |
B |
$3.95 |
$9,871 |
D/D |
2,500 |
52,500 |
2.74 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical OfficerOffi |
• – – |
2011-07-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2011-07-31 |
4 |
A |
$7.00 |
$350,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
